Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Scand J Med Sci Sports ; 23(2): e96-101, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23134144

ABSTRACT

Delayed onset muscle soreness (DOMS) is reduced when the same exercise is repeated after a certain interval. However, the mechanism for this adaptation, called a repeated bout effect, is still not well understood. Recently, we showed that upregulated nerve growth factor (NGF) triggered by B2 bradykinin receptor (B2R) activation in exercised muscle was responsible for DOMS. In this study, we investigated whether NGF upregulation was reduced after repeated bouts of exercise in rats, and if so, whether this change occurred upstream of B2R. A bout of 500 lengthening contractions (LC) was applied on day 0 and again 5 days later. DOMS was evaluated by the mechanical withdrawal threshold of the exercised extensor digitorum longus (EDL) muscle. Mechanical hyperalgesia and NGF mRNA upregulation in EDL were observed after the first LC, but not after the second LC. We then injected HOE140, a B2R antagonist with effects lasting only several hours, once before the first LC. This blocked the development of mechanical hyperalgesia and NGF mRNA upregulation not only after the first LC but also after the second LC. This suggests that adaptation occurred upstream of B2R, as the influence of the first LC was limited to that area by HOE140.


Subject(s)
Hyperalgesia/physiopathology , Muscle, Skeletal/metabolism , Nerve Growth Factor/metabolism , Physical Conditioning, Animal , Up-Regulation/physiology , Animals , Anti-Inflammatory Agents, Non-Steroidal/administration & dosage , Bradykinin/administration & dosage , Bradykinin/analogs & derivatives , Bradykinin B2 Receptor Antagonists , Hyperalgesia/prevention & control , Injections, Subcutaneous , Male , Muscle Contraction/physiology , Nerve Growth Factor/genetics , RNA, Messenger/metabolism , Rats , Rats, Sprague-Dawley , Receptor, Bradykinin B2/physiology , Up-Regulation/drug effects
2.
Biosci Biotechnol Biochem ; 61(8): 1370-2, 1997 Aug.
Article in English | MEDLINE | ID: mdl-9301121

ABSTRACT

We evaluated the catalytic ability of 29 yeast strains to reduce ethyl acetoacetate (EA) in the presence of ethanol or glucose. In 18 yeast strains, the reduction in the presence of ethanol proceeded as well as in the presence of glucose. Among them, Kloeckera magna (AKU 4704) effectively catalyzed the NADPH-dependent reduction of EA in the presence of ethanol. In this reduction, 1 mol of EA was reduced by consuming 1 mol of ethanol. We found that the NADPH regeneration system responsible for EA reduction in K. magna was coupled with oxidation of acetaldehyde to acetic acid catalyzed by an NADP(+)-dependent aldehyde dehydrogenase.


Subject(s)
Acetoacetates/metabolism , Ethanol/metabolism , NADP/physiology , Yeasts/metabolism , NAD/metabolism , Oxidation-Reduction , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...